Inactive Instrument

Other languages CannaPharmaRX, Inc. Other OTC

Equities

CPMD

US13765D1090

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	May. 16
CannaPharmaRX, Inc. Receives First Purchase Order and Begins Shipment of Product	Mar. 14
CannaPharmaRX, Inc. Executes Multi-Year Supply Agreement with Ican to Create Distribution Network in the Latin Americas	Mar. 05
CannaPharmaRx, Inc Enters into Strategic Supply Agreement with Cantek Holdings	Feb. 16
CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17
CannaPharmaRX, Inc. Announces Executive Changes	23-10-13
CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-10-13
CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-09-22
CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-09-01
CannaPharmaRx Expands Board of Directors	23-08-25
CANNAPHARMARX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-06-23
CannaPharmaRX, Inc. Announces CEO Changes	23-06-23
CannaPharmaRX, Inc. Signs Supply Agreement with Y.S.A Holdings for Up to $15 Million Annually of Commercial Cannabis	23-03-30
CannaPharmaRX, Inc. completed the acquisition of LTB Management LLC.	23-03-20
CannaPharmaRX, Inc. agreed to acquire LTB Management LLC.	23-02-20
CannaPharmaRx Receives Canada Revenue Agency License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected	23-01-11
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond	22-12-22
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million	22-12-21
CannaPharmaRx, Inc Receives Cultivation License from Health Canada and Projects 2023 Revenue over $30 Million	22-12-21
CannaPharmaRX, Inc. Provides Revenue Guidance for the Full Year 2023	22-12-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CannaPharmaRX, Inc. Other OTC

Equities

CPMD

US13765D1090

Other languages

Filters